title: Developments in heart failure 2010.
abstract: In spite of substantial improvement in outcomes in the past 2 decades, we continue to face significant challenges in treating patients with HF. There have been several epidemiologic, pathophysiologic, and randomized controlled trials evaluating different treatment modalities published in the past year. In this review, we summarize the most relevant studies that we believe could significantly impact the understanding and management of HF.
authors: Division of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70001, USA. kgaddam@ochsner.org
authors: Krishna K
authors: KK
authors: Gaddam
authors: Tara
authors: T
authors: Jarreau
authors: Hector
authors: H
authors: Ventura
mesh_terms: D058406:Cardiac Resynchronization Therapy; D006333:Heart Failure / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome